We have identified a novel tRNA methyltransferase in Saccharomyces cerevisiae that we designate Trm9. This enzyme, the product of theYML014w gene, catalyzes the esterification of modified uridine nucleotides, resulting in the formation of 5-methylcarbonylmethyluridine in tRNA Arg3 and 5-methylcarbonylmethyl-2-thiouridine in tRNA Glu . In intact yeast cells, disruption of the TRM9 gene results in the complete loss of these modified wobble bases and increased sensitivity at 37°C to paromomycin, a translational inhibitor. These results suggest a role for this potentially reversible methyl esterification reaction when cells are under stress.
In the last few years, it has become increasingly evident that S-adenosylmethionine (AdoMet)-dependent methyltransferases play a wide range of roles in cell physiology. Unlike other covalent modifications such as phosphorylation that occur mainly on proteins, methylation has been observed in DNA, RNA, proteins, lipids, polysaccharides, and small molecules (15, 35, 36, 38) . As a result of such diversity, identifying the methyltransferases and their substrates has been challenging. Although more than 25 methylated nucleotides have been documented for eukaryotic tRNAs alone, only a few of the corresponding enzymes and their genes have been identified (16, 47) .
In 1999, using conserved AdoMet binding motifs, we identified 26 putative methyltransferases (designated F1 to F26) encoded by the genome of the yeast Saccharomyces cerevisiae (40) . Biochemically, we have been able to show that two of these species are in fact methyltransferases; F3 (YDR465c) catalyzes the transfer of a methyl group to the delta-nitrogen atom of arginine residues in a novel protein posttranslational reaction (40, 58) , while F9 (YER175c) catalyzes the methyl esterification of the small molecule trans-aconitate (9) . Recently, F1 (YDL201w) was found to be responsible for formation of 7-methylguanosine at position 46 of tRNA (3) .
One major approach in identifying novel enzymes has been the comparison of the methylation spectra of strains lacking the putative methyltransferase and those of their isogenic wildtype parents by separation techniques such as sodium dodecyl sulfate (SDS) gel electrophoresis (26, 59 ). In the yeast S. cerevisiae, one can study biological methylation in vivo by incubating cells with
S-adenosyl-L-[methyl-
3 H]methionine ([ 3 H]AdoMet), the major biological methyl donor (26) . As a result, all methyl-accepting species such as RNAs, proteins, and small molecules can become radiolabeled and the fate of the methylated species can be followed biochemically. One can then look for differences in the methylation spectra between a mutant strain and its parent.
In all domains of life, tRNAs are highly modified posttranscriptionally (46, 47) . Methylation reactions account for the majority of these modifications. In the yeast S. cerevisiae, eight tRNA methyltransferases have been identified so far. The TRM1 gene product forms N 2 ,N 2 -dimethylguanosine at position 26 (14) . TRM2 encodes a protein that forms 5-methyluridine at position 54 (41) . TRM3 encodes a protein that catalyzes methylation on the 2Ј-O-ribose moiety of guanosine 18 (11) . TRM4 encodes a methyltransferase that forms 5-methylcytosine at positions 34, 40, 48, and 49 (37) . The TRM5 gene product forms 1-methylguanosine (m 1 G37) at position 37 and 1-methylinosine (m 1 I) and participates in Y-base (yW) formation (8) . The GCD14 gene product is part of a complex that forms 1-methyladenosine (4). Trm7 was identified as a methyltransferase that forms 2Ј-O-methylribose in the anticodon loop (43) . Recently, Trm8, working in a complex, was found to be required for formation of 7-methylguanosine at position 46 of tRNA (3) .
In this paper, we present evidence for the identification of the F6 (YML014w) candidate methyltransferase as the enzyme responsible for the esterifications of the modified 5-methylcarbonylmethyluridine (mcm 5 U) and 5-methylcarbonylmethyl-2-thiouridine (mcm 5 s 2 U) wobble bases in tRNA. We show that deletion of the F6 gene can lead to hypo-methyl esterification of tRNA at these bases in vivo. In addition, we show that the F6 gene product can methyl esterify tRNA in vitro, and we have now designated the F6 gene TRM9. Finally, we show that trm9 deletion mutants are hypersensitive to the translational inhibitor paromomycin at elevated temperatures, suggesting the importance of the methyl-esterified bases during heat shock.
MATERIALS AND METHODS
S. cerevisiae strains. Strain BY4742 (MAT␣ his⌬1 leu2⌬0 lys2⌬0 ura3⌬0) and the F6 (YML014w) kanamycin insert deletion strain in the BY4742 background were obtained from ResGen/Invitrogen (Carlsbad, Calif.). In this work, we designated the F6 deletion strain HKY101 (BY4742 trm9::Kan r ). The CEN.PK2-1C strain (MAT␣ ura3 his3 leu2 trp1) was a gift from Cathy Clarke, University of California-Los Angeles. Strain HKY102 (CEN.PK2-1c trm9::TRP1) was made using a PCR-based methodology with forward primer 5Ј-ATGGAGATAAACC AAGCGGCTGAAAAAGAACAGGAGTATGCCGCGGTGGCCGCTCTA-3Ј, reverse primer 5Ј-TCATCTCTTCTGGGCCACCACCCACCAATTGTCGC GGCATCGATAAGCTTGATATCGA-3Ј, and template plasmid pBluescript KS(ϩ)-TRP1 (6) . To generate the expression vector pRS316-TRM9, PCR methodology was used to amplify a 1,292-bp genomic fragment that contains the entire coding sequence of TRM9 and 452 bp upstream of the TRM9 gene. The forward primer (5Ј-GCCGGATCCGGGACTTTGTTGTTGATAGAGTCCG G-3Ј) contains BamHI site-flanking sequences and the reverse primer (5Ј-TAA GTCGACTCATCTCTTCTGGGCCACCACCAC-3Ј) contains SalI site-flanking sequences. The HKY111 strain, in which the wild-type TRM9 gene is replaced in the yeast genome by a fusion of TRM9 with an N-terminal hemagglutinin (HA) epitope-encoding segment under the control of the GAL1 promoter, was prepared as described previously (26) . Briefly, specific primers included a forward primer containing nucleotides Ϫ90 to Ϫ51 of the promoter region of YML014w incorporated into the 5Ј end of the F1 sequence and a reverse primer containing nucleotides ϩ50 to ϩ11 of YML014w incorporated into the 5Ј end of the R1 sequence (26) .
In vivo labeling and preparation of cell extracts. Strains of S. cerevisiae were grown to early log phase (optical density at 600 nm [OD 600 ] of between 0.6 and 0. 3 H]AdoMet concentration of 2 M. Cells were incubated in a gyratory shaker at 225 rpm for 30 min at 30°C, pelleted as described above, and washed twice with 1 ml of water.
The cell pellet was then resuspended in 50 l of lysis buffer (1% SDS [wt/vol] and 0.67 mM phenylmethylsulfonyl fluoride). Glass beads (0.2 g and 0.5 mm in diameter; Biospec Products, Inc., Bartlesville, Okla.) were added to the cell suspension, and the mixture was vortexed for 1 min, followed by incubation on ice for another 1 min. The vortexing step was repeated seven times. The extract was collected into a new tube, and another 50 l of lysis buffer was added to the beads and vortexed for 30 s to wash the remaining protein from the beads. This washed extract was then pooled with the original extract.
SDS gel electrophoresis and analysis of 3 H-methylated species. Approximately 50 l of the extract was mixed with an equal volume of concentrated gel electrophoresis sample buffer (3.5% [vol/vol] ␤-mercaptoethanol, 6% [wt/vol] SDS, 0.18 M Tris-HCl [pH. 6.8], 10% glycerol, 0.005% [wt/vol] bromophenol blue), incubated at 100°C for 5 min, and loaded onto a 1.5-mm-thick slab gel containing a stacking gel and a 10.5-cm-long resolving gel. The resolving gel was made from 10% (wt/vol) acrylamide and 0.34% (wt/vol) N,N-methylenebisacrylamide. Molecular mass standards (20-l aliquots of Bio-Rad low-molecular-weight standard, no. 161-0304, each at 2 mg/ml) were mixed with 20 l of sample buffer; 10 l was loaded into wells. Electrophoresis was performed at 20 mA until the dye front ran off the end of the resolving gel (32) . Gels were stained for 15 min in 0.1% Coomassie brilliant blue in 50% (vol/vol) methanol and 10% (vol/vol) acetic acid in water and then destained overnight at room temperature in 5% (vol/vol) methanol and 10% (vol/vol) acetic acid in water. The gels were vacuumdried at 65°C onto Whatman 3MM chromatography paper.
Dried gels were cut into 3-mm-thick slices that were 8 mm wide. To analyze gel slices for 3 H radioactivity in methyl ester linkages, 150 l of 1.5 M Na 2 CO 3 (pH 12) was added to each dried gel slice in a 1.5-ml polypropylene microcentrifuge tube. The tubes were gently placed into 20-ml scintillation vials containing 5 ml of Safety Solve counting fluid (Research Products International, Mt. Prospect, Ill.) so that no mixing occurred, and the vials were tightly capped. Vials were incubated at 37°C for 24 h to allow [ 3 H]methanol derived from base hydrolysis of methyl esters to diffuse in the vapor phase from the microcentrifuge tubes to the scintillation fluid. Scintillations in vials were counted using a Beckman LS6500 scintillation counter. To determine the total level of 3 H radioactivity present in each gel slice, 1 ml of 30% hydrogen peroxide was added gently to each microcentrifuge tube containing the gel slice after the scintillations in the vials were counted to measure [ 3 H]methanol levels. Vials were capped loosely and incubated at 37°C for an additional 24 h to allow for the digestion of the gel slice. After the vials were shaken to mix completely the contents of the microcentrifuge tube with the scintillation fluid, scintillations in the vials were recounted.
tRNA extraction and digestion. Yeast cells grown in 50 or 500 ml of YPD to log phase (OD 600 of 0.5 to 1.0) at 30°C were harvested by centrifugation for 5 min at 1,300 ϫ g at 4°C. The cells were resuspended in 300 l of 0.9% NaCl per 10 OD units of cells, and 2 volumes of phenol were then added to the suspension. The mixture was rotated gently at room temperature for 30 min. Chloroform (0.1 volume) was then added to the mixture, and the samples were incubated for an additional 15 min at room temperature. The samples were spun down at 10,600 ϫ g for 20 min. The aqueous phase was collected and mixed with 2.5 volumes of ethanol and 0.1 volume of 20% potassium acetate to precipitate RNA. tRNA was purified with the 2 M LiCl extraction method as described previously (5) . The tRNA pellet was washed twice with 80% ethanol and finally dissolved in water or 2.4 M tetraethylammonium chloride. tRNA was digested as previously described (18, 44) . Briefly, 50 l (100 to 200 g of RNA as determined by A 260 ) of tRNA was heat denatured at 90°C for 2 min and 5 l of 10 mM zinc sulfate and 10 l (200 U per ml) of nuclease P1 (Boehringer-Mannheim, Mannheim, Germany) were added. The mixture was incubated at 37°C for 16 h. Ten microliters of 0.5 M Tris buffer (pH 8.0) and 10 l (100 U per ml) of alkaline phosphatase (bacterial type III; Sigma) were added. The mixture was incubated at 37°C for 2 h.
Purification of specific tRNAs. To isolate specific tRNA species, the total tRNA extract described above was hybridized to matrix-bound oligonucleotides. Synthetic nucleotides containing biotin at the 5Ј end were designed to specifically hybridize to S. cerevisiae tRNA Arg3 or tRNA
Glu
. Biotinylated primers were synthesized that were specific for tRNA Arg3 and tRNA Glu and contained 35 nucleotides complementary to the 5Ј ends up to position 34, at which the mcm 5 U or mcm 5 s 2 U nucleotides are present. The probe (0.5 nmol) was bound to Dynabeads M-280 with streptavidin covalently attached to the surface, according to the recommendation of the manufacturer (Dynal A.S., Olso, Norway). Briefly, the beads were washed three times in the high salt buffer (5 mM Tris-HCl, 0.5 mM EDTA, 1 M NaCl). The beads were resuspended in 250 l of the high salt buffer and 10 l (1 nmol) of biotinylated synthetic probes. The mixture was incubated at room temperature for 15 min. Beads were washed three times with the high salt buffer. The hybridization method used here is described elsewhere (49) . Briefly, tRNA (50 to 200 g), dissolved in 2.4 M tetraethylammonium chloride, was denatured at 60°C for 3 min and then mixed with the streptavidinbound oligonucleotide beads at 15°C for 30 min. The beads were washed three times with 2.4 M tetraethylammonium chloride, and then bound tRNA was eluted after heating at 60°C for 3 min in 100 l of 2.4 M tetraethylammonium chloride. tRNA was concentrated and desalted by centrifugation by using Centricon 10 columns (Amicon, Beverly, Mass.). (44), digested tRNA was injected onto a C 18 reverse-phase column (Supelcosil; 5-m-diameter beads, 4.6-mm inside diameter, and 250-mm length) equilibrated in solvent A (5 mM ammonium acetate, pH 6.0) for 15 min and eluted at 1 ml/min at 25°C with increasing solvent B (40% acetonitrile in 60% water) concentrations. Amounts of time (in minutes) and percentages of A and B were as follows: 0, 100, and 0; 3, 100, and 0; 5.8, 98, and 2; 7.2, 97, and 3; 10, 95, and 5; 25, 75, and 25; 30, 50, and 50; 34, 25, and 75; 37, 25, and 75; 43, 0, and 100; and 48, 0, and 100, respectively. The nucleotides were detected using a UV detector (Waters Lambda-Max model 489) set at 254 nm. The fractions were collected at either at 1-or 0.5-min intervals. The collected fractions were used directly for the base-labile assay (described below) or dried overnight under a vacuum for mass spectrometry.
High-pressure liquid chromatography (HPLC). In a modification of the method of Pomerantz and McCloskey
HPLC fractions were analyzed for [ 3 H]methyl esters by mixing 100 to 150 l with NaOH to give a 1 M solution in a 200-l final volume to form [ 3 H]methanol. The hydrolysate was spotted onto a 1.5-by 8-cm piece of Whatman 3MM paper and suspended in the neck of a 20-ml scintillation vial above 5 ml of Safety Solve scintillation fluid. After 2 h at room temperature, the paper was removed and the scintillations in the vial were counted to measure the level of [ 3 H]methanol that had transferred to the fluid in the vapor phase.
Mass spectrometry. A Perkin-Elmer Sciex API III triple quadrupole mass spectrometer was used as previously described (27) . HPLC fractions containing nucleosides were analyzed by direct injection (15 l) into a mixture of wateracetonitrile-formic acid (50/50/0.1, vol/vol/vol). Normal spectra were obtained by scanning from an m/z of 200 to an m/z of 600 (0.3-Da step size, 30-msec dwell time, 6.0 s/scan, and orifice voltage of 60). Ion series were transformed using version 3.3 of MacSpec software. For tandem mass spectrometry (MS/MS) analysis, positive ion spectra of Q1 preselected parent ions were generated by collisionally induced dissociation (10% nitrogen in argon) with a collision gas thickness instrument setting (CGT) of 100 and an R 0 -R 2 offset of 20 V via scanning of Q3 from an m/z of 50 to an m/z of 400 (step size, 0.3 Da; dwell time, 30 ms; scan time, 5.02 s; orifice voltage, 60).
Preparation of saponified tRNA. Yeast tRNA was saponified as described previously (29) . Briefly, 1 ml of 0.5% of a commercial preparation of yeast tRNA (Boehringer-Mannheim) was mixed with 125 l of 1 M NaOH and the mixture was incubated at room temperature for 10 min. The solution was neutralized with 125 l of 1 M acetic acid. This preparation was used directly in the in vitro reactions.
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In vitro methylation of immunoprecipitated HA-tagged protein.
Genomically HA-tagged TRM9 gene product was immunoprecipitated from extracts of HKY111 cells (100 OD 600 units) as described previously (26) . Briefly, the protein-bound beads were resuspended in 150 l of buffer containing 50 mM Tris-HCl (pH 7.5) and 150 mM NaCl. An in vitro reaction mixture containing 5 l of [ 3 H]AdoMet (final concentration of 1.4 M in hydrochloric acid-ethanol diluted 9:1 [pH 2.0 to 2.5]), 40 l of beads, and various amounts of commercially purchased baker's yeast tRNA (Boehringer-Mannheim) was incubated at 37°C for 30 min. The reaction was stopped using 2ϫ gel electrophoresis sample buffer, and the [ 3 H]methyl ester counts were measured as described previously (26) . Preparation of a GST-Trm9 fusion protein. Plasmid pAN105 was made by Agnieszka Niewmierzycka in our laboratory to express a glutathione-S-transferase (GST)-Trm9 fusion protein (39) . Briefly, DNA including the open reading frame of YML014w (TRM9) was amplified by PCR from yeast genomic DNA by using primers containing a BamHI site in the 5Ј end (CTAGGATCCAACATG GAGATAAACC) and an EcoRI site in the 3Ј end (CTAGAATTCACCTTCA TCTCTTCTG). The amplified products and the plasmid pGEX-2T (Amersham Biosciences) were then each digested with EcoRI and BamHI. The digested insert was ligated into the digested vector in frame with the GST coding region to encode a GST-Trm9 fusion protein. Escherichia coli DH5␣ cells were transformed with the ligation reaction, and the correct clone was selected by restriction analysis. The GST fusion protein was expressed by IPTG (isopropyl-␤-Dthiogalactopyranoside; 1 mM final concentration) induction of a 2-liter culture of cells in Luria-Bertani broth containing 100 g of ampicillin/ml at an OD 600 of 0.4. After 3 h, the cells were spun down and washed twice, and the pellet was resuspended in 25 ml of a mixture of 140 mM NaCl, 2.7 mM KCl, 10 mM Na 2 HPO 4 , and 1.8 mM KH 2 PO 4 (pH 7.3) containing a dissolved protease cocktail tablet (Roche, Inc.). The resuspended cells were sonicated for 5 min, and the mixture was spun down by centrifugation at 18,600 ϫ g for 15 min at 4°C. The supernatant was transferred to 0.5 ml of a 50% glutathione-Sepharose 4B slurry (Amersham Biosciences) and shaken gently at 4°C for 1 h. Beads were spun down and washed three times with the lysis buffer. The fusion protein was eluted using 1 ml of 10 mM reduced glutathione-50 mM Tris-HCl (pH 8.0).
RESULTS
In vivo identification of a novel RNA methyltransferase. We labeled methylated cellular components of strains of the yeast S. cerevisiae by incubating intact cells with the biological methyl donor [ 3 H]AdoMet. We then fractionated extracts by SDS gel electrophoresis, measuring [ 3 H]methyl-esterified species with an assay in which gel slices are treated with base to release [ 3 H]methanol, which is then detected in a vapor phase assay for volatile radioactivity (26, 59 ). In Fig. 1 , we summarize a comparison of [ 3 H]methyl-esterified species of the candidate methyltransferase F6 (YML014w) from a wild-type parent and a knockout strain. A significant reduction of methylation was observed in the 21-kDa region of the mutant compared to that in its isogenic parent, suggesting that the substrate of the F6 methyltransferase eluted at this position. It has been shown previously that the majority of methyl-esterified species in the 21-kDa region actually are modified RNA species rather than proteins (23) .
In order to confirm that the F6-dependent methylation in the 21-kDa region is that of an RNA species, we treated cellular extracts of in vivo-radiolabeled yeast cells with either proteinase K or RNase A. Proteinase K treatment eliminated almost all of the methyl ester radioactivity in the gel except in the 21-kDa region, where much of the radioactivity was preserved (data not shown). On the other hand, when extracts were treated with RNase A, almost all the methyl ester radioactivity at the 21-kDa position disappeared (Fig. 1) . We conclude that the methyl esterification reduced in the F6 deletion mutant is present in RNA.
F6 is a tRNA methyltransferase (Trm9) responsible for the methylation of mcm 5 U and mcm 5 s 2 U nucleosides. We focused on tRNA methylation because tRNAs would be expected to migrate in the 21-kDa region of SDS gels. tRNA was extracted from in vivo [ 3 H]AdoMet-radiolabeled cells and was subsequently hydrolyzed to nucleosides. The resulting nucleosides were separated by HPLC, and the fractions were analyzed either by direct counting for total radioactivity or by the vapor phase assay for [ 3 H]methyl esters. No large differences were observed in the patterns of total radioactivity in F6 deletion strains, suggesting that the F6 gene product is not one of the major tRNA methylated species (data not shown). However, when the methyl ester radioactivity levels were compared, it was found that two of the major species were completely missing in the F6 deletion strain (Fig. 2) . One of these missing species eluted at 26 min (fraction 52) and the other at 32 min (fraction 64). Two candidate modified nucleosides that would be expected to elute at these positions are mcm 5 5 U eluted exactly with the 26-min peak missing in the F6 deletion mutant and mcm 5 s 2 U eluted exactly with the 32-min peak also absent in the F6 deletion mutant (data not shown). We thus designate the F6 (YML014w) gene TRM9 (for tRNA methyltransferase).
Mass spectrometry was used to directly determine the structure of the modified nucleosides that were not present in the trm9 deletion strain. tRNA was purified in large quantities from both the wild-type and the mutant strains, digested into nucleosides, and fractionated by HPLC (Fig. 3) . The digested tRNA samples were mixed with tracer amounts of radiolabeled Fig. 2 ) to identify the nonradiolabeled materials in the bulk tRNA preparations. Two small peaks, present in the wild-type preparation at 26 and 32 min (Fig. 3) , corresponded with radioactivity; both the A 254 peaks were missing in the corresponding fractions from the trm9 deletion strain (Fig. 3) . Fractions containing the methyl ester and fractions that eluted immediately before or after were analyzed in an electrospray quadrupole mass spectrometer. In the analysis of the 26-min fraction, the only marked difference found between samples from the wild-type and mutant strains was an ion of m/z of 316.9 corresponding to that expected for the M ϩ H ϩ species of mcm 5 U (317.0). This ion was present only in the 26-min fraction eluting with the tracer radioactivity; it was not observed in adjacent fractions (data not shown). To confirm that this species is mcm 5 U, the fractions were subjected to MS/MS to examine the pattern of ions after fragmentation. The pattern of ions observed was exactly consistent with the mcm 5 U structure (Fig. 4A) . The same type of analysis was done for the 32-min fraction. In this case, TRM9-dependent peaks of m/z 332.9 and 355.1 were found corresponding to the M ϩ H ϩ and M ϩ Na ϩ forms of mcm 5 s 2 U (data not shown). The product ions of the 333.0-m/z precursor ion were consistent with the mcm 5 s 2 U chemical structure (Fig. 4B) . We conclude that the deletion strain lacking the TRM9 gene does not have the two highly modified nucleosides mcm 5 U and mcm 5 s 2 U. The Trm9 methyltransferase modifies yeast tRNA Arg3 and tRNA Glu . We asked which yeast tRNAs contain methyl-esterified nucleotides and whether these would be absent in the trm9 deletion strain. It has previously been reported that tRNA Arg3 and tRNA Glu of S. cerevisiae contain mcm 5 U and mcm 5 s 2 U modifications, respectively, at the wobble position 34 (28, 30, 31) . Therefore, each of these specific tRNAs was purified from in vivo [ 3 H]AdoMet-labeled wild-type and mutant strains by using complementary oligonucleotides coupled to magnetic beads. After the purified tRNAs were digested into nucleosides, the mixture was separated by HPLC and fractions were analyzed for [ 3 H]methyl esters (Fig. 5) . For digested tRNA Arg3 , a peak of [ 3 H]methyl esters was seen only at 26.5 min and was absent in the trm9 mutant (Fig. 5A) . When purified tRNA
Glu from wild-type cell digests was examined, only one peak of methyl ester radioactivity was found in the position corresponding to mcm 5 s 2 U at 33 min in digests of wild-type cells and no radioactive peak was found in digests of the trm9 deletion strain (Fig. 5B) . Thus, we conclude that the tRNA Arg3 and tRNA Glu species from the trm9 deletion mutant lack the methyl-esterified nucleosides at the wobble position 34 .
In vitro analysis shows that Trm9 catalyzes the methyl esterification reaction. We then questioned whether the methyl esterification reactions that are dependent upon the TRM9 gene in vivo could be catalyzed by the TRM9 gene product in vitro. With the use of a saponified preparation of tRNA enriched with carboxylic acid-methyl-accepting substrates, it was found that both wild-type and Trm9-overexpressing extracts of yeast catalyzed significant incorporation of methyl esters into tRNA whereas trm9 mutant extracts demonstrated no signifi-FIG. 2. HPLC fractionation of methyl-esterified tRNA nucleosides. Total tRNA was extracted from in vivo-radiolabeled cells (10 OD units) as described in Materials and Methods. Subsequently, tRNA was digested with P1 nuclease and alkaline phosphatase to generate free nucleosides and then fractionated by HPLC as described in Materials and Methods. Methyl ester radioactivity was measured by adding 100 l of 2 N NaOH to 100 l of each fraction and measuring vapor phase [ 3 H]methanol as described in Materials and Methods. Symbols: ᮀ, wild-type strain BY4742; OE, F6 deletion mutant HKY101. cant incorporation compared to background controls in which extract or tRNA was absent (Table 1) . Importantly, the level of Trm9-dependent methyl esterification observed with nonsaponified tRNA was much lower. This indicates that a free carboxylate group generated by saponification is the substrate for the Trm9-catalyzed methylation reaction (Table 1) . To confirm that the TRM9 gene product is the enzyme responsible for the methyl esterification, this gene product was purified using monoclonal antibodies to immunoprecipitate Trm9-HA-tagged protein from extracts of cells grown in galactose in which the protein was expressed. We subsequently asked whether this preparation could methylate the commercial mixture of tRNA species as described above. When volatile [ 3 H]methyl esters were measured, significant radioactivity was found only when the enzyme and tRNA substrates were present (Table 1, experiment 2). When cells were grown in glucose in which the Trm9-HA protein would not be expressed, no significant radioactivity was found (Table 1, experiment 3) .
Genome-wide analysis of yeast protein complexes has suggested that the Trm9 protein is present in a complex with another putative methyltransferase, F8 (YDR140w), as well as three other gene products (YNR050c, YOL124c, and YNR046w) (17) . The deletion mutants lacking these interacting proteins were examined, with the exception of the YNR046w deletion mutant, since deletion of YNRO46w is lethal. All deletion mutants were found to contain the mcm 5 U and mcm 5 s 2 U modified nucleosides (Fig. 6 ). To directly show that the Trm9 protein can catalyze methyl ester formation in the absence of other yeast proteins, we generated a GST-Trm9 fusion protein in E. coli cells that have no homolog of the TRM9 gene and that lack mcm 5 U and mcm 5 s 2 U modified nucleosides. In Fig. 7 , we show that the VOL. 23, 2003 NOVEL METHYLTRANSFERASE FOR MODIFIED URIDINE RESIDUES 9287 purified fusion protein catalyzes the formation of methyl esters in both mcm 5 U and mcm 5 s 2 U. No methyl ester formation is seen when the GST-Trm9 fusion protein is incubated in the absence of tRNA or when an unrelated GST fusion protein is used (Fig. 7) . At this point, it is unclear whether potential protein partners may enhance the catalytic activity. However, it is clear that the Trm9 polypeptide can itself catalyze the methyl esterification reactions leading to the two modified nucleosides.
Sequence analysis of Trm9. A BLAST search of the amino acid sequence encoded by the TRM9 gene of S. cerevisiae revealed that homologs are present in all eukaryotes for which the complete genomes have been sequenced, including fungi, worms, flies, plants, and mammals (Fig. 8) . A multialignment of sequences from the species S. cerevisiae, Schizosaccharomyces pombe, Caenorhabditis elegans, Drosophilia melanogaster, and Homo sapiens demonstrates strong sequence similarity in the region containing the conserved AdoMet binding motifs (40) and in a C-terminal region including the S. cerevisiae sequence RYYHLYRELEL at residues 244 to 251. The sequence identities in the region of the yeast protein at residues 244 to 251 are especially interesting in that they may define residues involved in specific interactions with the substrates (tRNA).
Sensitivity of a trm9 deletion strain to an inhibitor of protein translation at elevated temperatures. To understand the physiological roles of Trm9, the deletion mutant strain HKY101 was subjected to adverse conditions such as elevated temperatures and UV exposure, and no major difference was observed between the mutant strain and its isogenic parent BY4742 (data not shown). The growth of the trm9 deletion strain was also examined in various media containing nonfermentable sugars such as ethanol and glycerol as the sole carbon source, in media lacking the amino acid arginine, in media containing the arginine analog L-canavanine, and in media containing the were used to purify the tRNAs from either the wild-type parent BY4742 or the HKY101 trm9 deletion strain. Isolated tRNA was digested with P1 nuclease and alkaline phosphatase to generate free nucleosides that were fractionated by HPLC as described in the legend to Fig. 2 . One hundred microliters of each fraction was used for measuring the methyl ester radioactivity as described in the legend to 
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protein translational inhibitor paromomycin, but again no significant phenotypic difference from the parent strain was observed (data not shown). However, the presence of the kanamycin resistance cassette in the HKY101 trm9 mutant would complicate the analysis for related protein synthesis inhibitors such as paromomycin. We therefore created a new trm9 knockout strain (designated HKY102) in which the TRM9 gene is disrupted by TRP1 rather than the kanamycin cassette. Upon examination of the new deletion strain for phenotypic differences, the HKY102 strain mutant appears to be much more sensitive than its isogenic parent to paromomycin at 37°C but not at 30°C (Fig. 9) . To determine whether the sensitivity phenotype is based solely on the lack of the TRM9 gene product, a rescue experiment was done in which the TRM9 gene, under its native promoter, was expressed in the HKY102 strain via a yeast centromer plasmid. The lack of sensitivity to paromomycin in this strain shows that the effect is due to the TRM9 gene product (Fig. 9) .
DISCUSSION
In this work, we demonstrate that the Trm9 methyltransferase is responsible for the methylation of wobble bases at position 34. It is the first described enzyme that catalyzes the potentially reversible methyl esterification of tRNA species.
Uridine residues at the wobble position 34 are generally modified. In E. coli the modification is either of the xo 5 U (5-hydroxyuridine derivative) type or the xm 5 (s 2 ) U(m) (5-methyluridine, 5-methyl-2-thiouridine, or 5-2Ј-O-methyluridine) type. The xo 5 U modification is found in tRNAs in which the wobble base can recognize all four nucleotides in the codon (53) . Modified nucleosides of the xm 5 (s 2 ) U(m) type include 5-methylaminomethyl-2-thiouridine (mnm 5 s 2 U) and 5-carboxymethylaminomethyl-2Ј-O-methyluridine (cmnm 5 Um) in E. coli. They are found in tRNA families that can read A or G in the third position of the codon (12, 50 (42, 45) . These methylesterified modifications have been found only in eukaryotes to date. Their apparent absence in eubacteria and archaebacteria suggests additional functions for these modifications as organisms became more complex.
Crick's original wobble hypothesis proposed that U in position 34 of the anticodon recognizes both A and G in the third position of the codon (13) . With knowledge of the modifications of uridine residues in the wobble position, this hypothesis has now been revised to propose that the unmodified U at position 34 can recognize all four bases while the modified uridine residues are more restrictive and limit the recognition to only A and G, or to only one of these residues, at this position (33, 56) . As a result, disruption of the modification of this uridine residue may lead to misreading in the third posi- FIG. 6 . HPLC fractionation of methyl-esterified tRNA nucleosides from mutant yeast cells deficient in products potentially found in a complex with Trm9 (17) . Total tRNA was extracted from in vivoradiolabeled cells with mutations in the F8 (YDR140w), YNR050c, and YOL124c genes as well as in the TRM9 gene as described in the legend to Fig. 2 . Subsequently, tRNA was digested with P1 nuclease and subjected to alkaline phosphatase to generate free nucleosides, which were fractionated by HPLC. Methyl ester radioactivity was measured by adding 100 l of 2 N NaOH to 100 l of each fraction and measuring vapor phase Control experiments were performed in which no GST fusion protein was added (F), in which GST-Trm9 was incubated without tRNA (E), or in which an unrelated GST fusion protein, GST-Rmt1, was used (OE).
VOL. 23, 2003 NOVEL METHYLTRANSFERASE FOR MODIFIED URIDINE RESIDUEStion of the codon and ultimately the incorporation of the wrong amino acid into the protein (57) . In vitro studies have shed some light onto the possible functions of the methyl esterification reaction in relation to these modified nucleotides. It has been shown that the mcm 5 U modification restricts the pairing of the anticodon UCU so that it recognizes the AGA codon only; yeast tRNA Arg3 lacking this modification can recognize both AGA and AGG codons (52) . Results of other in vitro binding and translation studies support the hypothesis that the 2-thiouridine (s 2 U 34 ) modification and the 5-methylaminoethyl (mnm 5 U 34 ) modification at position 34 restrict the reading of noncognate or near-cognate codons ending in U and C that specify different amino acids but allow recognition of their cognate codons ending in A or G (2, 20, 34, 54) . With nuclear magnetic resonance, it has been shown that an mnm 5 s 2 U 34 -hypermodified tRNA Lys stabilizes a U turn structure whereas the s 2 U 34 modification alone cannot bring about the same structural change (48) . It is interesting, however, that in vivo studies using E. coli mutants lacking mnm 5 s 2 U 34 or s 2 U 34 actually demonstrate reduced rather than increased misreading of asparagine codons (22) . It is clear that further work is needed to fully understand the role of these modifications.
What is the consequence of the loss of the Trm9 methyltransferase identified in yeast cells? Mutant cells are clearly viable under a number of conditions tested. However, we have been able to demonstrate sensitivity of trm9 mutants to paromomycin at elevated temperatures (Fig. 9) . Paromomycin is an aminoglycoside antibiotic that has been found to interact with the ribosomal A site (10, 51) . It is possible that the trm9 mutant lacking the methyl ester at the wobble position incorporates incorrect amino acids at a significant rate and that this leads to its sensitivity to paromomycin at the higher temperatures. Strains with TRM9 mutations were also found in a genomewide screen of viable diploid deletion mutants of S. cerevisiae for gamma-ray sensitivity (7) . These mutants also showed sensitivity to bleomycin (a DNA-damaging agent) and resistance to camptothecin (a topoisomerase I inhibitor) and hydroxyurea (an inhibitor of DNA replication). Although we have not confirmed these phenotypes in our haploid deletion mutants, pleiotropic effects may be expected from the disruption of the function of two (or more) tRNA species. In humans, we note that a mutation in a tRNA
Lys species results in a defect in the modification of its wobble 2-thiouridine residue that disturbs the codon-anticodon interaction and is associated with an epilepsy linked to abnormal "ragged-red" muscle fibers (55) . Additionally, in at least one host-pathogen interaction, the modified nucleoside mcm 5 s 2 U found in human tRNA Lys3 plays a key role in controlling the primer-template interaction in the reverse transcription initiation complex of human immunodeficiency virus type 1 (24, 25) .
Among the eight tRNA methyltransferases in yeast described previously, only the Gcd10/Gcd14 methyltransferase has been shown to be essential (4). However, a deletion strain lacking TRM5, which is responsible for modification of m 1 G37, m 1 I, and yW, was found to grow very poorly (8) . In addition, a deletion strain lacking TRM7, responsible for 2Ј-O-methylribose in the anticodon loop, showed slow growth and sensitivity to paromomycin (43) . Although the tRNA methyltransferases are evolutionarily conserved among many organisms, which points to essential roles, the generally nonlethal mutant phenotypes suggest subtle roles in fine-tuning of tRNA function under a variety of physiological conditions.
We examined the subcellular localization of Trm9 in yeast cells by using a green fluorescent protein fusion construct and found Trm9 to be present in both nuclei and cytoplasm (data not shown). For those tRNA methyltransferases of which the subcellular localization patterns have been determined, the enzymes are found in either the nucleus or the cytoplasm. Trm1, Trm4, and Gcd10/Gcd14 are found in the nucleus (2, 12, 32) , whereas Trm7 is found to be cytoplasmic (43) .
In two yeast tRNA methyltransferases (Gcd10/Gcd14 and Trm8/Trm82), the cellular function requires more than one polypeptide chain in a complex (3, 4) , and it has been suggested that this situation may be more general (1) . It was of interest to us that at least two steps are required to form mcm 5 U and mcm 5 s 2 U from the precursor U. These reactions include the addition of the sulfur atom, the formation of the carboxyl-methyl group on carbon-5, and the methyl esterification step performed by Trm9. It is not clear whether Trm9 can also perform some or all of the other steps mentioned above. The TRM9 gene product has been reported to be associated with four other gene products in a high-throughput pull-down screen (17) . However, we show here that deletion mutants lacking one of three of these genes all show the same modification of mcm 5 required for one or more of these steps. Nevertheless, YNR046w has no methyltransferase signature motifs and has not been associated with Trm9 in a two-hybrid screen (data not shown). Our study has described the first enzyme that can catalyze the methyl esterification of a nucleobase, in this case mcm 5 U and mcm 5 s 2 U in yeast tRNA. In gram-negative bacteria, a structurally related methyl-esterified nucleobase, uridine 5-oxyacetic acid methyl ester (mcmo 5 U), containing an ether moiety is found in several tRNA species (21) . A pathway for the biosynthesis of mcmo 5 U has been suggested in which hydroxylation of C-5 is followed by a methylation step and one or more reactions resulting in the addition of a carboxyl group (21) . It is unclear whether the biosynthetic pathways of mcm 5 U and mcm 5 s 2 U may also involve a similar methylated precursor, in this case 5-methyluridine. Determination of the biosynthetic pathways may be complicated by specific structural requirements of the tRNA substrate as well (19) . In any case, neither the gene nor the protein for the methyl esterification reaction has been identified in this bacterial system and we observe no prokaryotic homologs of the Trm9 protein. FIG. 9 . Sensitivity of trm9 deletion strains to paromomycin. (A) Yeast strains (wild-type parent CEN.PK2-1CHKY102 and the trm9⌬ HKY102 strain) were grown to log phase at 30°C in the presence of 300 g of paromomycin/ml. Cells (0.5 OD 600 unit) were collected and resuspended in 200 l of sterilized water. Ten microliters of the suspension was diluted in fivefold serial dilutions and plated onto YPD plates, and colonies were allowed to grow for 3 days. (B) Experimental conditions were the same as those described for panel A except that strains were grown at 37°C. (C) Yeast strains containing either the vector pRS316 or the TRM9 expression vector pRS316-TRM9 were grown at 37°C and plated as described above but in a synthetic dextrose medium lacking uracil.
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